Correction: Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.
作者信息
Martinez Miceala, Ono Nadia, Planutiene Marina, Planutis Kestutis, Nelson Edward L, Holcombe Randall F
机构信息
Tisch Cancer Institute of Mt, Sinai School of Medicine, New York, NY, USA.
出版信息
Cancer Cell Int. 2013 Aug 15;13(1):80. doi: 10.1186/1475-2867-13-80.
Abstract
摘要
相似文献
1
Correction: Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.更正：粒细胞巨噬细胞刺激因子（GM-CSF）可增加循环树突状细胞，但并不能消除接受化疗的转移性结直肠癌患者适应性细胞免疫的抑制作用。
Cancer Cell Int. 2013 Aug 15;13(1):80. doi: 10.1186/1475-2867-13-80.
2
Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.粒细胞-巨噬细胞集落刺激因子（GM-CSF）增加循环树突状细胞，但不能消除转移性结直肠癌患者接受化疗时适应性细胞免疫的抑制作用。
Cancer Cell Int. 2012 Jan 23;12(1):2. doi: 10.1186/1475-2867-12-2.
3
Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.在集落刺激因子（G-CSF、GM-CSF、IL-1、IL-2、M-CSF）的I期临床试验中，接受大剂量联合烷化剂化疗及自体骨髓支持的患者的造血恢复情况
Ann Hematol. 1993 Dec;67(6):267-76. doi: 10.1007/BF01696346.
4
A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.一项随机试验，比较粒细胞-巨噬细胞集落刺激因子加粒细胞集落刺激因子联合应用与粒细胞集落刺激因子用于动员造血祖细胞产品中树突状细胞亚群的效果。
Biol Blood Marrow Transplant. 2004 Dec;10(12):848-57. doi: 10.1016/j.bbmt.2004.07.008.
6
Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).接受恶性疾病强化化疗患者的造血生长因子：粒细胞集落刺激因子（G-CSF）、粒细胞-巨噬细胞集落刺激因子（GM-CSF）、白细胞介素-3（IL-3）和Flt-3配体（Flt3L）的研究。
Eur Cytokine Netw. 2001 Apr-Jun;12(2):231-8.
7
9
Granulocyte-macrophage colony-stimulating factor increases the proportion of circulating dendritic cells after autologous but not after allogeneic hematopoietic stem cell transplantation.粒细胞-巨噬细胞集落刺激因子可增加自体造血干细胞移植后而非异基因造血干细胞移植后循环树突状细胞的比例。
Cytotherapy. 2011 Aug;13(7):888-96. doi: 10.3109/14653249.2011.579956. Epub 2011 May 24.
10
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.大剂量环磷酰胺后三种细胞因子方案的比较效果：粒细胞集落刺激因子、粒细胞-巨噬细胞集落刺激因子（GM-CSF）以及白细胞介素-3与GM-CSF序贯治疗。
J Clin Oncol. 1999 Apr;17(4):1296. doi: 10.1200/JCO.1999.17.4.1296.
引用本文的文献
1
Downregulation of Runx3 is closely related to the decreased Th1-associated factors in patients with gastric carcinoma.Runx3的下调与胃癌患者中Th1相关因子的减少密切相关。
Tumour Biol. 2014 Dec;35(12):12235-44. doi: 10.1007/s13277-014-2532-6. Epub 2014 Oct 1.
本文引用的文献
1
Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.粒细胞-巨噬细胞集落刺激因子（GM-CSF）增加循环树突状细胞，但不能消除转移性结直肠癌患者接受化疗时适应性细胞免疫的抑制作用。
Cancer Cell Int. 2012 Jan 23;12(1):2. doi: 10.1186/1475-2867-12-2.
Zotero 插件